<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00983112</url>
  </required_header>
  <id_info>
    <org_study_id>2009-010802-12</org_study_id>
    <secondary_id>2009-003</secondary_id>
    <nct_id>NCT00983112</nct_id>
  </id_info>
  <brief_title>Evicel Study on the Peri-operative Bleeding in Total Knee Prothesis Surgery</brief_title>
  <official_title>Impact of a Biological Glue (Evicel®) on the Peri Operative Bleeding in Total Knee Prothesis Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinique Mutualiste Chirurgicale de la Loire</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Clinique Mutualiste Chirurgicale de la Loire</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Knee prothesis surgery is responsible of a risk of thrombosis and hemorrhage. To prevent
      thrombosis, patients have systematic anticoagulation after surgery which are responsible of
      hemorrhage. A local glue which improve local coagulation and have no impact of thrombosis can
      be a solution to limit hemorrhage. The purpose of this trial is to study the impact of a
      biological glue administration on the bleeding loss at five days after a total knee
      prosthesis surgery operation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The orthopaedic surgeon administers a local pulverisation of the biological glue during the
      surgery.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2009</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <primary_completion_date type="Anticipated">September 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Study the impact of a biological glue administration on the bleeding loss at Day 5 after a total knee prosthesis surgery operation</measure>
    <time_frame>Day 5</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The rate of cell saver transfusion the surgery day</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The rate of red blood cell transfusion</measure>
    <time_frame>Day 1, Day 3, Day 5 and at the hospitalisation end</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The hematoma size</measure>
    <time_frame>Day 1, Day 3, Day 5 and at the hospitalisation end</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The site incision state</measure>
    <time_frame>Day 1, Day 3, Day 5 and at the hospitalisation end</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The rest and movement pain</measure>
    <time_frame>Day 1, Day 3, Day 5 and at the hospitalisation end</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The antalgic consumption</measure>
    <time_frame>Day 1, Day 3, Day 5 and at the hospitalisation end</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The functional recovering index</measure>
    <time_frame>Day 1, Day 3, Day 5, at the hospitalisation end and at 1 month, 3 months and 6 months post-operative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major rate or clinically significative hemorrhage.</measure>
    <time_frame>Between Day 1 and the hospitalisation end</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infectious complications.</measure>
    <time_frame>Between Day 1 and the hospitalisation end</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The rate of SUSARs.</measure>
    <time_frame>Between Day 1 and the end of the study (6 months post-operative)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The rate ot thrombotics events.</measure>
    <time_frame>Between Day 1 and the hospitalisation end</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">116</enrollment>
  <condition>Thrombosis</condition>
  <arm_group>
    <arm_group_label>Evicel</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Human Fibrinogen and human thrombin (Evicel)</intervention_name>
    <description>Product to be applied intraoperatively. No further administration will take place after this.</description>
    <arm_group_label>Evicel</arm_group_label>
    <other_name>Evicel</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium Chlorure (Physiological saline)</intervention_name>
    <description>Sterile concentration, local use.</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Physiological saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient affiliated with or a beneficiary of a social security category:

               -  having more than 18 years old

               -  having signed the informed consent form

               -  having undergone a total knee prosthesis surgery operation

        Exclusion Criteria:

          -  incapacity to understand the protocol

          -  patient having taken anti-coagulants or clopidogrel 10 days before excepted aspirin to
             a dose equal or less than 160 mg/day

          -  women having period so generally women having less than 50 years old

          -  PT less than 60% and ACT taller than 10 sec

          -  contra-indications to the drug

          -  Erytropoietine treatment required before surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Denis BAYLOT, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinique Mutualiste Chirurgicale</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Denis BAYLOT, MD-PhD</last_name>
    <phone>+33(0)477828391</phone>
    <email>dbaylot@mutualite-loire.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Saint-Etienne</name>
      <address>
        <city>Saint-Etienne</city>
        <zip>42000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>, MD-PhD</last_name>
    </contact>
    <investigator>
      <last_name>Denis BAYLOT, MD-PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>François CHALENCON, MD-PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Paul PASSOT, MD-PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 18, 2009</study_first_submitted>
  <study_first_submitted_qc>September 22, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 23, 2009</study_first_posted>
  <last_update_submitted>April 24, 2012</last_update_submitted>
  <last_update_submitted_qc>April 24, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 25, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Gonarthrosis</keyword>
  <keyword>Knee prosthesis insertion</keyword>
  <keyword>Bleeding</keyword>
  <keyword>Undergoing a total knee prothesis surgery</keyword>
  <keyword>knee prothesis surgery</keyword>
  <keyword>Knee arthrosis</keyword>
  <keyword>Thrombosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Thrombosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thrombin</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>June 3, 2015</submitted>
    <returned>June 17, 2015</returned>
    <submitted>November 10, 2015</submitted>
    <returned>December 14, 2015</returned>
    <submitted>May 27, 2016</submitted>
    <returned>July 6, 2016</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

